Universitair Ziekenhuis Leuven, often shortened to UZ Leuven, is an academic hospital in Leuven, Belgium, associated with the university KU Leuven. It consists of five campuses as of 2016; Gasthuisberg, Lubbeek, Pellenberg, Sint-Pieter and Sint-Rafaël. The hospital has 1,995 beds and over 9,000 employees.

There are 1,995 beds in University Hospitals KU Leuven.

During the past decade, University Hospitals KU Leuven conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospitals KU Leuven" #1 sponsor was "PTC Therapeutics" with 2 trials, followed by "Baki Topal" with 1 trials sponsored, "Becton, Dickinson and Company" with 1 trials sponsored, "KU Leuven" with 1 trials sponsored and "PDC*line Pharma SAS" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospitals KU Leuven" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator and "FGK Clinical Research GmbH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University Hospitals KU Leuven" are "Becker Muscular Dystrophy" (2 trials), "Duchenne Muscular Dystrophy" (2 trials), "Dystrophinopathy" (1 trials), "Lung Neoplasm" (1 trials) and "Non Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "University Hospitals KU Leuven" in a lesser frequency.

Most popular intervention types in "University Hospitals KU Leuven" are "Drug" (4 trials), "Device" (2 trials), "Procedure" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ataluren" (2 trials), "Alimta Injectable Product" (1 trials), "Durvalumab 50 MG/ML" (1 trials), "EBUS-TBNA needle" (1 trials) and "ERAMIP" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Hospitals KU Leuven" are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospitals KU Leuven". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in University Hospitals KU Leuven, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Hospitals KU Leuven, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".